SCHEMBL6039476

SCHEMBL6039476

O=C(O)C1CCCN1C(=O)Cc1cc(O)c(CC(=O)N2CCC[C@@H]2C(=O)O)cc1O

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACE P12821 3/20 0.51
THRB P10828 1/20 0.45
ALOX12 P18054 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MVD P53602 2/20 0.44
CA2 P00918 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2448827 1.00 ACE (0.51) ACETHRBALOX12KMT2AALDH1A1
SCHEMBL2448832 1.00 ACE (0.51) ACETHRBALOX12KMT2AALDH1A1
SCHEMBL5540025 0.93 ACE (0.46) ACETHRBALOX12KMT2AALDH1A1
SCHEMBL6221760 0.81 KDM4E (0.49) ACEALDH1A1SMN1; SMN2CA2CHRM2
SCHEMBL6221764 0.81 KDM4E (0.49) ACEALDH1A1SMN1; SMN2CA2CHRM2
SCHEMBL9538232 0.81 ALDH1A1 (0.48) ACEKMT2AALDH1A1
SCHEMBL6039762 0.80 ACE (0.55) ACETHRBALOX12KMT2AALDH1A1
SCHEMBL3183667 0.80 ACE (0.55) ACETHRBALOX12KMT2AALDH1A1
SCHEMBL6786426 0.80 ACE (0.55) ACETHRBALOX12KMT2AALDH1A1
SCHEMBL3183657 0.80 ACE (0.55) ACETHRBALOX12KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633345-A1 COMPOUNDS INHIBITING THE BINDING OF SAP FOR TREATING OSTEOARTHRITIS Pentraxin Therapeutics Limited (GB) 2006-03-15 EP disclosed
WO-2004108131-A1 COMPOUNDS INHIBITING THE BINDING OF SAP FOR TREATING OSTEOARTHRITIS PENTRAXIN THERAPEUTICS LIMITED (GB) 2004-12-16 WO disclosed